Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies

被引:3202
作者
Lazarou, J
Pomeranz, BH
Corey, PN
机构
[1] Univ Toronto, Dept Physiol, Toronto, ON M5S 3G5, Canada
[2] Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada
[3] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5S 3G5, Canada
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1998年 / 279卷 / 15期
关键词
D O I
10.1001/jama.279.15.1200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-To estimate the incidence of serious and fatal adverse drug reactions (ADR) in hospital patients. Data Sources.-Four electronic databases were searched from 1966 to 1996. Study Selection.-Of 153, we selected 39 prospective studies from US hospitals. Data Extraction.-Data extracted independently by 2 investigators were analyzed by a random-effects model, To obtain the overall incidence of ADRs in hospitalized patients, we combined the incidence of ADRs occurring while in the hospital plus the incidence of ADRs causing admission to hospital. We excluded errors in drug administration, noncompliance, overdose, drug abuse, therapeutic failures, and possible ADRs. Serious ADRs were defined as those that required hospitalization, were permanently disabling, or resulted in death. Data Synthesis.-The overall incidence of serious ADRs was 6.7% (95% confidence interval [CI], 5.2%-8.2%) and of fatal ADRs was 0.32% (95% CI, 0.23%-0.41%) of hospitalized patients. We estimated that in 1994 overall 2 216 000 (1721 000-2 711 000) hospitalized patients had serious ADRs and 106 000 (76 000-137 000) had fatal ADRs, making these reactions between the fourth and sixth leading cause of death. Conclusions.-The incidence of serious and fatal ADRs in US hospitals was found to be extremely high, While our results must be viewed with circumspection because of heterogeneity among studies and small biases in the samples, these data nevertheless suggest that ADRs represent an important clinical issue.
引用
收藏
页码:1200 / 1205
页数:6
相关论文
共 59 条
  • [21] DOMECQ C, 1980, INT J CLIN PHARM TH, V18, P362
  • [22] DRUG-RELATED HOSPITAL ADMISSIONS
    EINARSON, TR
    [J]. ANNALS OF PHARMACOTHERAPY, 1993, 27 (7-8) : 832 - 840
  • [23] PREVENTING ADVERSE DRUG EVENTS IN HOSPITALIZED-PATIENTS
    EVANS, RS
    PESTOTNIK, SL
    CLASSEN, DC
    HORN, SD
    BASS, SB
    BURKE, JP
    [J]. ANNALS OF PHARMACOTHERAPY, 1994, 28 (04) : 523 - 527
  • [24] COMMUNITY-HOSPITAL PHARMACIST DETECTION OF DRUG-RELATED PROBLEMS UPON PATIENT ADMISSION TO SMALL HOSPITALS
    FRISK, PA
    COOPER, JW
    CAMPBELL, NA
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (07): : 738 - 742
  • [25] GARDNER P, 1970, CLIN PHARMACOL THER, V11, P802
  • [26] Gray JB, 1996, NY TIMES, pA11
  • [27] PREDISPOSING FACTORS IN ADVERSE REACTIONS TO DRUGS
    HURWITZ, N
    [J]. BRITISH MEDICAL JOURNAL, 1969, 1 (5643) : 536 - &
  • [28] INTENSIVE HOSPITAL MONITORING OF ADVERSE REACTIONS TO DRUGS
    HURWITZ, N
    WADE, OL
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1969, 1 (5643): : 531 - +
  • [29] THE EFFECTS OF THE DRG-BASED PROSPECTIVE PAYMENT SYSTEM ON QUALITY OF CARE FOR HOSPITALIZED MEDICARE PATIENTS - AN INTRODUCTION TO THE SERIES
    KAHN, KL
    RUBENSTEIN, LV
    DRAPER, D
    KOSECOFF, J
    ROGERS, WH
    KEELER, EB
    BROOK, RH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (15): : 1953 - 1955
  • [30] KARCH FE, 1976, CLIN PHARMACOL THER, V19, P489